Worldwide Mycoplasma Testing Industry to 2027 – Growing Concerns Over Cell Contamination Presents Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Mycoplasma Testing Market Share, Size, Trends, Industry Analysis Report, By Product; By Technology; By Application; By End Use; By Regions; Segment Forecast, 2020-2027” report has been added to ResearchAndMarkets.com’s offering.

The global mycoplasma testing market expected to reach USD 1.59 billion by 2027, according to the study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising need of researchers, market players, and scientific research contributors for sterile cell cultures, i.e. free from mycoplasma contaminations, concerning investments and research funding, and the introduction of novel technologies to increase its assessment capabilities. Moreover, the marketplace is focusing on automation to reduce contamination risks, human borne errors, and quick turnaround time.

The global mycoplasma testing industry is fragmented based on product, technology, application, end-use, and region. In terms of product, the market is segmented into instruments, kits & reagents, and services. Based on technology, the global mycoplasma testing industry is further bifurcated into PCR, ELISA, direct assay, indirect assay, microbial culture techniques, and enzymatic methods.

Based on application, the mycoplasma testing industry is further bifurcated into cell line, virus, end of production cells, and others. Based on end-use, the market for mycoplasma testing is further bifurcated into academic research institutes, cell banks, contract research organizations, pharmaceutical & biotechnology companies, and others.

• Thermo Fisher Scientific, Inc.
• Bionique Testing Laboratories, Inc.
• Lonza Group Ltd.
• Merck KGaA
• Roche Diagnostics
• Meridian Bioscience, Inc.
• Charles River Laboratories International, Inc.
• Savyon Diagnostics
• American Type Culture Collection
• InvivoGen
• PromoCell GmbH
• Nelson Laboratories Fairfield, Inc.
• Others

Segment Highlights

• The kits and reagents market segment accounted for the largest revenue share in 2019 on account of the regular use of consumables for mycoplasma analysis during cell culture research work and several other uses.
• Based on technology, the PCR market segment is projected to constitute almost half of the market in 2027. The preciseness, specificity, and high efficiency are few attributes make PCR reliable for mycoplasma analysis.
• Pharmaceutical & biotechnology companies market segment accounted for over 25% of the revenue share in 2019 owing to the growing demand for mycoplasma testing for cell culture research and several research & development activities
• North American market is dominating the global mycoplasma testing industry. Positive funding scenario and the presence of competent regulatory authorities favouring the growth in the region.

Key Topics Covered:

1. Introduction

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview

3.1.1. Data Mining

3.2. Data Sources

3.2.1. Primary Sources

3.2.2. Secondary Sources

4. Mycoplasma Testing Market Insights

4.1. Mycoplasma Testing – Industry snapshot

4.2. Mycoplasma Testing Market Dynamics

4.2.1. Drivers and Opportunities

4.2.1.1. Growing concerns over cell contamination

4.2.1.2. Innovations in rapid testing

4.2.2. Restraints and Challenges

4.2.2.1. High degree of consolidation among market players

4.3. Porter’s Five Forces Analysis

4.4. PESTLE Analysis

4.5. Mycoplasma Testing Market Industry trends

5. Mycoplasma Testing Market Assessment by Product

5.1. Key Findings

5.2. Introduction

5.3. Instruments

5.4. Kits & Reagents

6. Mycoplasma Testing Market Assessment by Technology

6.1. Key Findings

6.2. Introduction

6.3. PCR

6.4. ELISA

6.5. Direct Assay

6.6. Indirect Assay

6.7. Microbial Culture Techniques

6.8. Enzymatic Methods

7. Global Mycoplasma Testing Market, by Application

7.1. Key Findings

7.2. Introduction

7.3. Cell Line Testing

7.4. Virus Testing

7.5. End of Production Cells Testing

7.6. Others

8. Global Mycoplasma Testing Market, by End-Use

8.1. Key Findings

8.2. Introduction

8.3. Academic Research Institutes

8.4. Cell Banks

8.5. Contract Research Organizations

8.6. Pharmaceutical & Biotechnology Companies

8.7. Others

9. Mycoplasma Testing Market Assessment by Geography

9.1. Key findings

9.2. Introduction

9.3. Mycoplasma Testing Market – North America

9.4. Mycoplasma Testing Market – Europe

9.5. Mycoplasma Testing Market – Asia-Pacific

9.6. Mycoplasma Testing Market – Middle East & Africa

9.7. Mycoplasma Testing Market – Latin America

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis

10.1.1. Expansion

10.1.2. Acquisition

10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/iy0x53

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900